Your browser doesn't support javascript.
loading
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.
Garbe, Claus; Dummer, Reinhard; Amaral, Teresa; Amaria, Rodabe N; Ascierto, Paolo A; Burton, Elizabeth M; Dreno, Brigitte; Eggermont, Alexander M M; Hauschild, Axel; Hoeller, Christoph; Kaufmann, Roland; Lebbe, Celeste; Mandala, Mario; Menzies, Alexander M; Moreno, David; Michielin, Olivier; Nathan, Paul; Patel, Sapna P; Robert, Caroline; Schadendorf, Dirk; Lorigan, Paul C; Scolyer, Richard A; Tawbi, Hussein A; van de Wiel, Bart A; Blank, Christian; Long, Georgina V.
Affiliation
  • Garbe C; Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. claus.garbe@med.uni-tuebingen.de.
  • Dummer R; Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland. Reinhard.Dummer@usz.ch.
  • Amaral T; Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland. Reinhard.Dummer@usz.ch.
  • Amaria RN; Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Ascierto PA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Burton EM; Department of Skin Cancer, Cancer Immunotherapy and Development Therapeutics, Instituto Nazionale Tumouri IRCCS Fondazione G. Pascale, Napoli, Italy.
  • Dreno B; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Eggermont AMM; Nantes University, Nantes, France.
  • Hauschild A; Faculty of Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hoeller C; Comprehensive Cancer Centre Munich of the Technical University Munich and the Ludwig Maximilians University, Munich, Germany.
  • Kaufmann R; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.
  • Lebbe C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Mandala M; Department of Dermatology, Venerology and Allergology, Frankfurt University Hospital, Frankfurt, Germany.
  • Menzies AM; Université Paris Cite, AP-HP Department of Dermatology, Hôpital Saint-Louis Paris, Paris, France.
  • Moreno D; Department of Surgery and Medicine, Unit of Medical Oncology, University of Perugia, Perugia, Italy.
  • Michielin O; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Nathan P; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.
  • Patel SP; Faculty of Medicine & Health, The University of Sydney, Sydney, NSW, Australia.
  • Robert C; Medical & Surgical Dermatology Service, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Schadendorf D; Department of Medical Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Lorigan PC; Mount Vernon Cancer Centre, Northwood, UK.
  • Scolyer RA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tawbi HA; Department of Medical Oncology, Gustave Roussy and Paris-Saclay University, Villejuif, France.
  • van de Wiel BA; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Blank C; German Cancer Consortium, Heidelberg Partner Site Essen, Essen, Germany.
  • Long GV; University of Manchester, Manchester, UK.
Nat Med ; 29(6): 1310-1312, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37193799

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Limits: Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2023 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Limits: Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2023 Document type: Article Affiliation country: Germany